Biological and clinical perspectives of TERT promoter mutation detection on bladder cancer diagnosis and management
L Cheng, S Zhang, M Wang, A Lopez-Beltran - Human Pathology, 2023 - Elsevier
The telomerase reverse transcriptase (TERT) promoter mutations are associated with
increased TERT mRNA and TERT protein levels, telomerase activity, and shorter but stable …
increased TERT mRNA and TERT protein levels, telomerase activity, and shorter but stable …
[HTML][HTML] The role of E3 ubiquitin ligases and deubiquitinases in bladder cancer development and immunotherapy
X Wang, Y Zhang, Y Wu, H Cheng, X Wang - Frontiers in Immunology, 2023 - frontiersin.org
Bladder cancer is one of the common malignant urothelial tumors. Post-translational
modification (PTMs), including ubiquitination, acetylation, methylation, and phosphorylation …
modification (PTMs), including ubiquitination, acetylation, methylation, and phosphorylation …
[HTML][HTML] Non-urothelial and urothelial variants of bladder cancer
E Yu, S Belay, W Li, JB Aragon-Ching - Cancer Treatment and Research …, 2022 - Elsevier
Non-urothelial bladder cancers make up a rare minority of all genitourinary (GU) tract
histologic cancers since urothelial cancer (UC) makes up the most common histologic …
histologic cancers since urothelial cancer (UC) makes up the most common histologic …
Squamous cell carcinoma of the bladder: Demographics and outcomes associated with surgery and radiotherapy
MC Larkins, M Pasli, A Bhatt… - Journal of Surgical …, 2024 - Wiley Online Library
Abstract Background and Objectives Squamous cell carcinoma of the bladder (SCCB) is a
rare disease composing 2%− 5% of all bladder cancers with no consensus regarding …
rare disease composing 2%− 5% of all bladder cancers with no consensus regarding …